SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-263299
Filing Date
2021-09-01
Accepted
2021-09-01 16:41:02
Documents
15
Period of Report
2021-09-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d183634d8k.htm   iXBRL 8-K 26335
2 EX-99.1 d183634dex991.htm EX-99.1 32235
6 GRAPHIC g183634g0901002904361.jpg GRAPHIC 4248
7 GRAPHIC g183634gra001.jpg GRAPHIC 14063
  Complete submission text file 0001193125-21-263299.txt   210538

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vivo-20210901.xsd EX-101.SCH 2921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20210901_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20210901_pre.xml EX-101.PRE 10972
8 EXTRACTED XBRL INSTANCE DOCUMENT d183634d8k_htm.xml XML 3272
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 211230487
SIC: 2835 In Vitro & In Vivo Diagnostic Substances